In summary, the analysis of DEG of AML patients suggests that FLT3 ITD does not only control development of aberrant haematopoiesis but has an impact on BM niche formation for clonal development of FLT3 ITD-positive blasts. This evidence concerns the gene FLT3 and acute myeloid leukemia.